As of June 30, 2026 and December 31, 2025, the Company had reserved common stock, on an as-if converted basis, for issuance as follows (in thousands): | | | | | | | | | | | | | June 30,
2026 | | December 31,
2025 | K2 Warrants | 170 | | | 170 | | | Pre-Funded Warrants | 7,722 | | 4,622 | Stock options issued and outstanding from 2024, 2019 Equity Incentive Plan and Inducement Plan | 7,192 | | | 5,385 | Shares available for future grant from 2024 Equity Incentive Plan and Inducement Plan | 717 | | | 975 | Total | 15,801 | | | 11,152 | | | The reserved common stock in the table above does not include (i) the number of shares of the Company’s common stock issuable upon conversion of the remaining amount of the Conversion Amount specified within the Amended Loan Agreement (see Note 4), (ii) the variable number of shares issuable pursuant to conversion of amounts funded under the Convertible Grant Agreement (see Note 4), and (iii) the variable number of shares issuable pursuant to terms of the Chase Agreement. |
|